SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors debate the impact of the upcoming AACR presentation and the final 80-event readout for its REGAL Phase 3 trial. Community discussions are heavily divided, with bulls highlighting potential clinical breakthroughs and long-term survival data, while bears point to trial protocol modifications and questions regarding efficacy versus the control arm.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid heightened anticipation for the Clarity Act, which proponents believe will provide the regulatory framework necessary for widespread institutional adoption and cross-border payment integration. While the community is actively debating the potential for a long-term price breakout, discourse remains sharply polarized between bullish investors anticipating a major supply shift and skeptical bears citing persistent range-bound performance.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is experiencing high volatility as traders react to reports of a potential executive order regarding the federal research and development of ibogaine for PTSD treatment. While some community members are bullish on the company's clinical prospects and the low-float setup, others are debating the sustainability of the price action, citing concerns over past dilution and the speculative nature of the news catalyst.

Highstreet

Highstreet is trending as traders speculate on a potential short squeeze, fueled by community interest in its low supply and a significant price retracement from recent highs. Investors are actively debating whether current levels represent an accumulation zone for a rebound or a persistent downward trend, with many monitoring whale movements and technical indicators for signs of a turnaround.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is trending as investors aggressively bet on a trend reversal, fueled by heavy options activity and bullish sentiment surrounding the stock's role as a leveraged proxy for Bitcoin. The community is actively debating the stock's structural shift to capital efficiency and its potential for a significant short squeeze as BTC prices recover.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is rallying as investors react to easing geopolitical tensions in the Strait of Hormuz and reports of potential diplomatic progress, fueling bullish sentiment across the crypto sector. The community is actively debating the sustainability of this price action, with many highlighting strong institutional inflows and long-term accumulation strategies while navigating persistent concerns over macroeconomic volatility.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending due to significant shareholder frustration surrounding the company's proposal to authorize future reverse stock splits, coupled with concerns over ongoing dilution despite recent positive insider buying from CEO Seth Lederman. While bullish investors point to growing prescription data and expanding insurance coverage for its core fibromyalgia treatment, the community remains deeply divided by the stock's persistent downward price action and the potential for further share issuance.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is trending as it navigates significant geopolitical demand, evidenced by high-level White House meetings aimed at accelerating the production of munitions and missile systems to replenish stockpiles. Investors are focused on its core role in defense infrastructure, including long-term contract awards for key platforms like the F-35 and PAC-3 interceptors, amid ongoing discussions regarding the defense sector's capacity to scale operations to meet mission-critical requirements.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing significant attention as it tests major resistance levels, bolstered by institutional accumulation and growing anticipation surrounding the upcoming Clarity Act. Market participants are actively debating the potential for a breakout, with sentiment heavily influenced by broader geopolitical stabilization and the asset's critical role in DeFi infrastructure.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is trending as investors weigh strong commercial momentum for its LGSOC combination therapy against valuation concerns, while the broader RAS/MAPK space remains highly active with recent competitor data releases and breakthrough designations. The community is actively debating the potential of the VS-7375 KRAS G12D inhibitor and scrutinizing management's capital strategy as they look for catalysts to bridge the current valuation gap.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PANW, $CRWD  $NET $ZS 
and all the other “top tier-best of breed” Cyber companies:
Just a weekend reminder &amp; what shorts have miscalculated: 
Cybersecurity isn’t just “stickier SaaS” it’s structurally different in kind.
It’s an adversarial domain. The threat scales with the technology. AI makes attacks more sophisticated, faster, &amp; more targeted, which means demand for defense doesn’t compress, it escalates. You’re not just managing a workflow, you’re fighting an opponent who also has the latest &amp; greatest AI tools. 
That’s not a war with a slow dinosaur anymore. That’s an arms race with no finish line.
Finally, the regulatory moat for cybersecurity is real. Compliance mandates, board liability, and insurer requirements create demand floors that productivity software doesn’t have.
I agree that the margin compression thesis works for SOME static software (SaaS) companies. That said, it’s much harder to apply to a category where the problem set actively grows alongside the solution set.

Dr Brett L Scarlett

StockTwits for iOS

Palo Alto Networks Inc

Crowdstrike Holdings Inc

Cloudflare Inc

Zscaler Inc

 
and all the other “top tier-best of breed” Cyber companies:
Just a weekend reminder & what shorts have miscalculated: 
Cybersecurity isn’t just “stickier SaaS” it’s structurally different in kind.
It’s an adversarial domain. The threat scales with the technology. AI makes attacks more sophisticated, faster, & more targeted, which means demand for defense doesn’t compress, it escalates. You’re not just managing a workflow, you’re fighting an opponent who also has the latest & greatest AI tools. 
That’s not a war with a slow dinosaur anymore. That’s an arms race with no finish line.
Finally, the regulatory moat for cybersecurity is real. Compliance mandates, board liability, and insurer requirements create demand floors that productivity software doesn’t have.
I agree that the margin compression thesis works for SOME static software (SaaS) companies. That said, it’s much harder to apply to a category where the problem set actively grows alongside the solution set.